Skip to content
CNS Clinical Research

Miami, Florida

CNS clinical trials in Miami, FL

82 CNS studies are recruiting participants at sites in Miami as of November 16, 2026, according to ClinicalTrials.gov. CNS Clinical Research can help you understand your options and connect with a study team.

Call (888) 520-7418
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Miami at a glance

  • 82 studies are recruiting at a site in Miami.
  • By phase: Phase 1/2 (1), Phase 2 (16), Phase 2/3 (1), Phase 3 (33), Phase 4 (7), No phase (10), Observational (14). Studies of devices and behavioral approaches have no phase.
  • By sponsor: industry (67), university, hospital or other (14), government (1).
  • By research area: Depression (27), Parkinson's Disease (15), Epilepsy (11), Migraine (10), Schizophrenia (10), Multiple Sclerosis (5), Bipolar Disorder (3), ADHD (1).
  • Most recent update to one of these records: November 16, 2026.

Depression studies recruiting in Miami

Basic details from each study's public record (the 30 most recently updated of 82). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder

    • Phase 2
    • Ages 18 to 70
    • All sexes
    Sponsor
    Supernus Pharmaceuticals, Inc.
    Study site
    Avantis Clinical Research
    Registry record
    NCT07226661 · updated
  2. E-Mindfulness Approaches for Living After Breast Cancer

    • Phase 3
    • Ages 18 to 50
    • All sexes
    Sponsor
    NRG Oncology
    Study sites
    UM Sylvester Comprehensive Cancer Center at Kendall · University of Miami Miller School of Medicine-Sylvester Cancer Center
    Registry record
    NCT06748222 · updated
  3. Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

    • Phase 3
    • Ages 18 to 65
    • All sexes
    Sponsor
    Intra-Cellular Therapies, Inc.
    Study sites
    Miami Jewish Health System · Premier Clinical Research Institute
    Registry record
    NCT05850689 · updated
  4. Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

    • Phase 3
    • Ages 10 to 17
    • All sexes
    Sponsor
    Intra-Cellular Therapies, Inc.
    Study sites
    Care Research Center Inc · Envision Trials LLC · HealthMed Clinical Center Inc
    Registry record
    NCT06372964 · updated
  5. Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

    • Phase 3
    • Ages 18 to 74
    • All sexes
    Sponsor
    Janssen Research & Development, LLC
    Study site
    Nuovida Research Center
    Registry record
    NCT06559306 · updated
  6. A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder

    • Phase 3
    • Ages 18 to 74
    • All sexes
    Sponsor
    Janssen Research & Development, LLC
    Study sites
    Nuovida Research Center · Pharmax Research Clinic Inc
    Registry record
    NCT07573176 · updated
  7. A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Janssen Research & Development, LLC
    Study site
    Pharmax Research Clinic Inc
    Registry record
    NCT07716098 · updated
  8. A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study sites
    Diverse Clinical Research · Quantix Research - Miami - Southwest 72nd Street
    Registry record
    NCT07775300 · updated
  9. Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Neurocrine Biosciences
    Study site
    Neurocrine Clinical Site
    Registry record
    NCT06966401 · updated
  10. A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Tonix Pharmaceuticals, Inc.
    Registry record
    NCT07621237 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Miami, FL on ClinicalTrials.gov.

Schizophrenia studies recruiting in Miami

  1. A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

    • Phase 2
    • Ages 55 to 90
    • All sexes
    Sponsor
    MapLight Therapeutics
    Registry record
    NCT06887192 · updated
  2. Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

    • Phase 3
    • Ages 5 to 17
    • All sexes
    Sponsor
    Intra-Cellular Therapies, Inc.
    Study sites
    Blue Medical Research · Care Research Center Inc · Columbus Clinical Services LLC
    Registry record
    NCT06229210 · updated
  3. A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

    • Phase 2
    • Ages 55 and older
    • All sexes
    Sponsor
    Intra-Cellular Therapies, Inc.
    Study sites
    Allied Biomedical Research Institute (ABRI), Inc · South Florida Research Phase I-IV · Sunshine Medical Solution
    Registry record
    NCT06540833 · updated
  4. Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study sites
    Banyan Behavioal Care Program - CSU · BioResearch Partner - Miami
    Registry record
    NCT07379827 · updated

Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Miami, FL on ClinicalTrials.gov.

Bipolar disorder studies recruiting in Miami

  1. A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)

    • Phase 3
    • Ages 18 to 65
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study site
    LCC Medical Research Institute
    Registry record
    NCT06951711 · updated

Source: ClinicalTrials.gov. Data processed . See every bipolar disorder study recruiting in Miami, FL on ClinicalTrials.gov.

Parkinson's disease studies recruiting in Miami

  1. Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    Boston Scientific Corporation
    Study site
    University of Miami Hospital
    Registry record
    NCT02071134 · updated
  2. Deep Brain Stimulation (DBS) Retrospective Outcomes Study

    • Observational
    • All ages
    • All sexes
    Sponsor
    Boston Scientific Corporation
    Study site
    University of Miami Hospital
    Registry record
    NCT03664609 · updated
  3. A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    Miami Cancer Institute at Baptist Health, Inc. ( Site 0214)
    Registry record
    NCT06623422 · updated
  4. A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

    • Phase 3
    • Ages 50 to 85
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Study site
    Baptist Hospital of Miami
    Registry record
    NCT07174310 · updated
  5. A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease

    • Phase 3
    • Ages 45 to 75
    • All sexes
    Sponsor
    BlueRock Therapeutics
    Study site
    University of Miami Health System - Neurology
    Registry record
    NCT06944522 · updated
  6. A Study of Buntanetap in Participants With PD

    • Phase 2/3
    • Ages 40 to 85
    • All sexes
    Sponsor
    Annovis Bio Inc.
    Study site
    Professional Research Center
    Registry record
    NCT07284784 · updated
  7. A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations

    • Phase 2
    • Ages 30 to 80
    • All sexes
    Sponsor
    Appello Pharmaceuticals, Inc.
    Study site
    University of Miami (Site #220)
    Registry record
    NCT07432958 · updated

Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Miami, FL on ClinicalTrials.gov.

Multiple sclerosis (MS) studies recruiting in Miami

  1. A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    TG Therapeutics, Inc.
    Study site
    TG Therapeutics Investigational Trial Site
    Registry record
    NCT06433752 · updated

Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Miami, FL on ClinicalTrials.gov.

Epilepsy studies recruiting in Miami

  1. Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits

    • Phase 4
    • Ages 18 and older
    • All sexes
    Sponsor
    VA Office of Research and Development
    Study site
    Miami VA Healthcare System, Miami, FL
    Registry record
    NCT04419272 · updated
  2. Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Rapport Therapeutics Inc.
    Registry record
    NCT07594119 · updated
  3. A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

    • Phase 3
    • Ages 12 and older
    • All sexes
    Sponsor
    Xenon Pharmaceuticals Inc.
    Study site
    Serenity Research Center, LLC
    Registry record
    NCT05667142 · updated
  4. Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Neurona Therapeutics
    Study site
    University of Miami
    Registry record
    NCT05135091 · updated

Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Miami, FL on ClinicalTrials.gov.

Migraine studies recruiting in Miami

  1. Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

    • Phase 4
    • Ages 18 to 70
    • All sexes
    Sponsor
    Mayo Clinic
    Study sites
    Apple Med Research · University of Miami
    Registry record
    NCT06972056 · updated
  2. Study of EVO756 in Adults With Migraine

    • Phase 2
    • Ages 18 to 64
    • All sexes
    Sponsor
    Evommune, Inc.
    Study sites
    Apple Medical Research Group, Inc · Blessed Healthcase & Research · Florida Research Center, Inc.
    Registry record
    NCT07616128 · updated
  3. A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    TriGemX Bio, Inc.
    Study site
    AppleMedical Research Group, LLC
    Registry record
    NCT07816367 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Miami, FL on ClinicalTrials.gov.

Ask about studies near Miami

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Florida

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 520-7418

or send a short form

How should we reach you?

Call